Clinical Trial Update: Rhodiola Rosea in Adults With Attention Deficit/Hyperactivity Disorder [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Rhodiola Rosea in adults with Attention Deficit/Hyperactivity Disorder; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Rhodiola Rosea

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: Attention Deficit/Hyperactivity Disorder | Phase 4 | Status: UNKNOWN